These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 17591692)

  • 1. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
    Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
    Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.
    Cheng X; Kao HY
    J Biol Chem; 2009 Dec; 284(52):36395-36404. PubMed ID: 19858209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain.
    Voss TC; Demarco IA; Booker CF; Day RN
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):33-47. PubMed ID: 15713534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.
    Jonas BA; Varlakhanova N; Hayakawa F; Goodson M; Privalsky ML
    Mol Endocrinol; 2007 Aug; 21(8):1924-39. PubMed ID: 17519355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
    Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
    Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
    Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
    Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.
    Hong W; Chen L; Li J; Yao Z
    Biochem Biophys Res Commun; 2010 May; 396(2):299-303. PubMed ID: 20406620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
    Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
    Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
    Smith CL; Nawaz Z; O'Malley BW
    Mol Endocrinol; 1997 Jun; 11(6):657-66. PubMed ID: 9171229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
    Hong SH; Wong CW; Privalsky ML
    Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
    De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
    Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.